1185767-02-5

Basic information

• Product Name: 5,7-Difluoro-quinoline-6-carbaldehyde
• Synonyms: 5,7-Difluoro-quinoline-6-carbaldehyde
• CAS NO: 1185767-02-5
• Molecular Formula: C10H5F2NO
• Molecular Weight: 193.15
• Mol File: 1185767-02-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5,7-Difluoro-quinoline-6-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5,7-Difluoro-quinoline-6-carbaldehyde(1185767-02-5)
• EPA Substance Registry System: 5,7-Difluoro-quinoline-6-carbaldehyde(1185767-02-5)

Safety Data

• Hazardous Substances Data: 1185767-02-5(Hazardous Substances Data)

Usage

General Description

5,7-Difluoro-quinoline-6-carbaldehyde is a chemical compound with the molecular formula C11H6F2NO. It is a fluorescent and aromatic aldehyde that contains two fluorine atoms. 5,7-Difluoro-quinoline-6-carbaldehyde is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also known for its potential biological activities, including antibacterial, antifungal, and antiproliferative effects. Additionally, 5,7-Difluoro-quinoline-6-carbaldehyde has been utilized as a building block in the development of novel materials and organic compounds for various industrial applications.

Upstream product

• 203302-95-8 4-bromo-3,5-difluorophenylamine 
• 372-39-4 3,5-difluoroaniline 
• 1022091-49-1 6-bromo-5,7-difluoroquinoline 
• 68-12-2 N,N-dimethyl-formamide 
• 1185767-03-6 6-vinyl-5,7-difluoroquinoline 

Relevant articles and documents

Quinoline compounds and preparation method thereof, and intermediate, pharmaceutical composition and application of quinoline compounds

The invention discloses quinoline compounds and a preparation method thereof, and an intermediate, a pharmaceutical composition and application of quinoline compounds. The invention provides quinoline compounds disclosed as Formula 1, and pharmaceutically acceptable salts, solvates, metabolites, metabolism precursors or pharmaceutical precursors thereof. The quinoline compounds have favorable inhibitory effects on tyrosine kinase C-Met, and can be used for preparing drugs for prevention, treatment or auxiliary treatment on multiple diseases related to C-Met expression or activity, and especially neoplastic diseases.

3-HETEROARYLMETHYL-IMIDAZO[1,2-B]PYRIDAZIN-6-YL DERIVATIVES AS C-MET TYROSINE KINASE MODULATORS

The invention relates to compounds of formula (I) and salts thereof, wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with